Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.
Zhao Y, Fay F, Hak S, Manuel Perez-Aguilar J, Sanchez-Gaytan BL, Goode B, Duivenvoorden R, de Lange Davies C, Bjørkøy A, Weinstein H, Fayad ZA, Pérez-Medina C, Mulder WJ.
Zhao Y, et al. Among authors: de lange davies c.
Nat Commun. 2016 Apr 13;7:11221. doi: 10.1038/ncomms11221.
Nat Commun. 2016.
PMID: 27071376
Free PMC article.